CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Grant or award Chief Financial Officer acquired 125,300 shares (grant or award)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 15,641 shares at $16.25 ($254,121)
- 4 Open-market sale President sold 74,084 shares at $16.25 ($1,203,650)
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Grant or award Chief Executive Officer acquired 475,178 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 187,636 shares (grant or award)
- 4 Grant or award President acquired 257,912 shares (grant or award)
- 8-K/A Event Executive or director change
- 4 Grant or award Director acquired 26,470 shares (grant or award)
- 4 Grant or award Director acquired 26,470 shares (grant or award)
- 4 Grant or award Director acquired 26,470 shares (grant or award)
- 8-K Event Impairment
- 4 Other disposition 10% owner disposed of 26,547,021 shares (other)
Page 11 of 14 · 267 filings